ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
My Liraglutide Results
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 243972" data-attributes="member: 3"><p>[URL unfurl="true"]https://pubmed.ncbi.nlm.nih.gov/36675601/[/URL]</p><p></p><p>Full paper attached (members only- Register on <a href="https://www.excelmale.com/forum/register/" target="_blank">Register</a> )</p><p></p><ul> <li data-xf-list-type="ul">Group A (<em>n</em> = 35): Patients with an active desire for fatherhood. They were prescribed conventional treatment for fertility using urofollitropin 150 IU subcutaneously (three times a week) associated with hCG 2000 IU subcutaneously (twice a week) for 4 months;</li> <li data-xf-list-type="ul"><strong><strong>Group B (<em>n</em> = 35): Patients with no active desire for fatherhood. They were prescribed liraglutide 0.6 mg subcutaneously every day for the first week, then 1.2 mg (second week), 1.8 mg (third week), 2.4 mg (fourth week), and 3.0 mg (from the fifth week for another three months);</strong></strong></li> <li data-xf-list-type="ul">Group C (<em>n</em> = 40): Patients who had already fathered a child and were not seeking fertility. They were prescribed transdermal testosterone gel (2%) at 60 mg every day for 4 months.</li> </ul><p>[ATTACH=full]28624[/ATTACH]</p><p>[ATTACH=full]28621[/ATTACH]</p><p></p><p>[ATTACH=full]28622[/ATTACH]</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 243972, member: 3"] [URL unfurl="true"]https://pubmed.ncbi.nlm.nih.gov/36675601/[/URL] Full paper attached (members only- Register on [URL="https://www.excelmale.com/forum/register/"]Register[/URL] ) [LIST] [*]Group A ([I]n[/I] = 35): Patients with an active desire for fatherhood. They were prescribed conventional treatment for fertility using urofollitropin 150 IU subcutaneously (three times a week) associated with hCG 2000 IU subcutaneously (twice a week) for 4 months; [*][B][B]Group B ([I]n[/I] = 35): Patients with no active desire for fatherhood. They were prescribed liraglutide 0.6 mg subcutaneously every day for the first week, then 1.2 mg (second week), 1.8 mg (third week), 2.4 mg (fourth week), and 3.0 mg (from the fifth week for another three months);[/B][/B] [*]Group C ([I]n[/I] = 40): Patients who had already fathered a child and were not seeking fertility. They were prescribed transdermal testosterone gel (2%) at 60 mg every day for 4 months. [/LIST] [ATTACH type="full" alt="weight loss.jpg"]28624[/ATTACH] [ATTACH type="full" alt="hormones after weight loss.jpg"]28621[/ATTACH] [ATTACH type="full" alt="sperm after weight loss.jpg"]28622[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
My Liraglutide Results
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top